Amid news of the splashy $4.8 billion Amicus buy, BioMarin has slipped in the discontinuation of a genetic liver disease ...
One of the biggest risk factors for developing liver cancer is a high-fat diet. A new study from MIT reveals how a fatty diet ...
Study Finds on MSN
Liver Cells Under Chronic Dietary Stress Show Cancer Warning Signs Years Before Tumors Appear
Your liver cells are forgetting how to do their jobs under dietary stress. Here's how that signals cancer risk years before ...
Researchers from Miguel Hernández University of Elche (UMH) in Spain have identified an effective strategy to reduce ...
As a malignant disease of the liver cells, hepatocellular carcinoma (HCC) is one of the main causes of cancer-related deaths. While the treatment options for this aggressive type of cancer remain ...
The development of hepatocellular carcinoma, liver cancer, is known to involve abnormal activation of a signaling pathway called Wnt; however, the underlying mechanisms have not been fully understood, ...
The U.S. Food and Drug Administration has qualified the first artificial intelligence tool designed to help doctors assess a ...
The combination of denifanstat and resmetirom was generally well-toleratedPharmacokinetic (PK) results support further development of the ...
The FDA has qualified AI-Based Histologic Measurement of MASH, or AIM-MASH AI Assist — the first AI drug development tool — ...
Pfizer announced Monday it was discontinuing the development of one of its obesity pill candidates due to elevated levels of liver enzymes being detected during clinical trials, while the development ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback